6533b830fe1ef96bd1297cd5
RESEARCH PRODUCT
Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: study protocol for the prospective multicentre OptimBioma study
Lucrecia YáñezSilvia Jiménez-jorgeClara M Rosso-fernándezGema Labrador-herreraNancy Rodríguez-torresMaría Eugenia Pachón-ibáñezYounes SmaniFrancisco José Márquez-malaverCarmen Limón RamosCarlos SolanoLourdes Vázquez-lópezMi KwonJoan Manuel Mora BarriosManuela Aguilar-guisadoIldefonso EspigadoAriadna Pérez MartínezPeña-muñoz FRebeca Bailen Almoroxsubject
medicine.medical_specialtymedicine.drug_classmedicine.medical_treatment1700Antibioticslcsh:MedicinemicrobiomeGraft vs Host DiseaseHematopoietic stem cell transplantationantibioticsAntimicrobial StewardshipFecesInternal medicinegraft versus host diseasemicrobiotamedicineHumansMulticenter Studies as Topic1506infectionsLongitudinal StudiesProspective StudiesAntibiotic prophylaxisbusiness.industryIncidence (epidemiology)lcsh:RHematopoietic Stem Cell TransplantationGeneral MedicineAntibiotic Prophylaxismedicine.diseaseTransplant RecipientsGastrointestinal MicrobiomeTransplantationObservational Studies as Topicsurgical procedures operativeGraft-versus-host diseaseResearch DesignCase-Control StudiesCohortObservational studybusinessHaematology (Incl Blood Transfusion)description
GETH (Grupo Español de Trasplante Hematopoyético y Terapia Celular).
year | journal | country | edition | language |
---|---|---|---|---|
2020-07-01 | BMJ Open |